These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 19291766)

  • 1. Fragile X screening: attitudes of genetic health professionals.
    Acharya K; Ross LF
    Am J Med Genet A; 2009 Feb; 149A(4):626-32. PubMed ID: 19291766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attitudes of genetic counselors towards expanding newborn screening and offering predictive genetic testing to children.
    Hiraki S; Ormond KE; Kim K; Ross LF
    Am J Med Genet A; 2006 Nov; 140(21):2312-9. PubMed ID: 17036312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attitudes toward prenatal screening and testing for Fragile X.
    Fanos JH; Spangner KA; Musci TJ
    Genet Med; 2006 Feb; 8(2):129-33. PubMed ID: 16481897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conflicts regarding genetic counseling for fragile X syndrome screening: a survey of clinical geneticists and genetic counselors in Israel.
    Lieberman S; Zuckerman S; Levy-Lahad E; Altarescu G
    Am J Med Genet A; 2011 Sep; 155A(9):2154-60. PubMed ID: 21834046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental and behavioral pediatricians' attitudes toward screening for fragile X.
    Acharya K; Schindler A
    Am J Intellect Dev Disabil; 2013 Jul; 118(4):284-93. PubMed ID: 23937370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of fragile X relatives with different attitudes toward terminating an affected pregnancy.
    Meryash DL
    Am J Ment Retard; 1992 Mar; 96(5):528-35. PubMed ID: 1562310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatricians' attitudes toward expanding newborn screening.
    Acharya K; Ackerman PD; Ross LF
    Pediatrics; 2005 Oct; 116(4):e476-84. PubMed ID: 16199673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of population screening for fragile X syndrome.
    Hill MK; Archibald AD; Cohen J; Metcalfe SA
    Genet Med; 2010 Jul; 12(7):396-410. PubMed ID: 20548240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attitudes toward population screening among people living with fragile X syndrome in the UK: 'I wouldn't wish him away, I'd just wish his fragile X syndrome away'.
    Boardman FK
    J Genet Couns; 2021 Feb; 30(1):85-97. PubMed ID: 33184995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attitudes toward fragile X mutation carrier testing from women identified in a general population survey.
    Anido A; Carlson LM; Sherman SL
    J Genet Couns; 2007 Feb; 16(1):97-104. PubMed ID: 17295053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An assessment of screening strategies for fragile X syndrome in the UK.
    Pembrey ME; Barnicoat AJ; Carmichael B; Bobrow M; Turner G
    Health Technol Assess; 2001; 5(7):1-95. PubMed ID: 11262423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caregiver opinions about fragile X population screening.
    Bailey DB; Bishop E; Raspa M; Skinner D
    Genet Med; 2012 Jan; 14(1):115-21. PubMed ID: 22237440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal carrier testing for fragile X: counseling issues and challenges.
    Musci TJ; Moyer K
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):61-70, Table of Contents. PubMed ID: 20494258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fragile-X carrier screening and the prevalence of premutation and full-mutation carriers in Israel.
    Toledano-Alhadef H; Basel-Vanagaite L; Magal N; Davidov B; Ehrlich S; Drasinover V; Taub E; Halpern GJ; Ginott N; Shohat M
    Am J Hum Genet; 2001 Aug; 69(2):351-60. PubMed ID: 11443541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fragile-X syndrome in east Finland: molecular approach to genetic and prenatal diagnosis.
    Ryynänen M; Pulkkinen L; Kirkinen P; Saarikoski S
    Am J Med Genet; 1994 Jul; 51(4):463-5. PubMed ID: 7943020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A five-year experience with fragile X screening of high-risk gravid women.
    Wenstrom KD; Descartes M; Franklin J; Cliver SP
    Am J Obstet Gynecol; 1999 Oct; 181(4):789-92. PubMed ID: 10521730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragile X syndrome carrier screening in the prenatal genetic counseling setting.
    Cronister A; DiMaio M; Mahoney MJ; Donnenfeld AE; Hallam S
    Genet Med; 2005 Apr; 7(4):246-50. PubMed ID: 15834242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Screening for fragile X syndrome. International experiences].
    Vuust J; Larsen LA; Grønskov K; Nørgaard-Pedersen B; Brøndum-Nielsen K
    Ugeskr Laeger; 2006 Oct; 168(43):3704-9. PubMed ID: 17069733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitudes and beliefs of pediatricians and genetic counselors regarding testing and screening for CF and G6PD: implications for policy.
    Koopmans J; Hiraki S; Ross LF
    Am J Med Genet A; 2006 Nov; 140(21):2305-11. PubMed ID: 17022079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for Fragile X Syndrome: parent attitudes and perspectives.
    Skinner D; Sparkman KL; Bailey DB
    Genet Med; 2003; 5(5):378-84. PubMed ID: 14501833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.